NAT2 and tuberculosis: The PopPK modelling approach incorporating several potential covariates including NAT2 genotype, anthropometric measures, and other clinical variables could provide a thrust for precise optimization of individual dosing regimens of isoniazid in TB patients in this era of precision therapy.